While the reduction in price target from $38 to $34 by BMO Capital could suggest a tempered outlook on Xencor's future stock performance, the maintenance of an Outperform rating indicates a continued positive view on the company's prospects. This mixed signal might lead to a neutral short-term impact on Xencor's stock price as investors weigh the lowered price target against the analyst's overall positive stance.